Current treatment approaches for rheumatoid arthritis (RA) primarily involve disease-modifying anti-rheumatic drugs (DMARDs) to achieve remission or low disease activity. However, remission is not achieved in most patients, and sustained remission over an extended period remains rare. (1) Consequently, there is a pressing need for new, effective tr